Literature DB >> 26487784

The advancement of human pluripotent stem cell-derived therapies into the clinic.

R Scott Thies, Charles E Murry.   

Abstract

There was an error published in Development 142, 3077-3084.On p. 3081, it was incorrectly stated that Dr Lorenz Studer's group is supported by the New York Stem Cell Foundation. The correct funding credit is the New York State Stem Cell Science program.The authors apologise to readers for this mistake.

Entities:  

Year:  2015        PMID: 26487784      PMCID: PMC6514393          DOI: 10.1242/dev.131250

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  1 in total

1.  Human Pluripotent Stem Cell-Derived Engineered Tissues: Clinical Considerations.

Authors:  Kelly R Stevens; Charles E Murry
Journal:  Cell Stem Cell       Date:  2018-03-01       Impact factor: 24.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.